|
Market Cap (2-Jul) $363,897,504 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 24 May 2022, 17:28. The announcement is not marked as price sensitive, and is 35 page(s) in length and 1.55MB in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 1.209% short sold according to ASIC data. It was ranked the 194th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Immutep Corporate Presentation | 24 May 2022, 17:28 |
| Immutep to Present at Investor Conferences | 20 May 2022, 8:22 |
| Leading Oncologists appointed to Clinical Advisory Board | 18 May 2022, 8:17 |
| New & significant data from AIPAC phase 2b trial in MBC | 4 May 2022, 18:54 |
You must be logged in to post a reply.
